BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30852045)

  • 1. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
    Thway K
    Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
    Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
    Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
    Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
    Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedifferentiated liposarcoma with lipoma-like well-differentiated liposarcoma: clinicopathological study of 30 cases, with particular attention to the comingling pattern of well- and dedifferentiated components: a proposal for regrouping of the present subclassification of well-differentiated liposarcoma and dedifferentiated liposarcoma.
    Iwasa Y; Nakashima Y
    Int J Surg Pathol; 2013 Feb; 21(1):15-21. PubMed ID: 22674916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
    Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel sclerosing atypical lipomatous tumor/well-differentiated liposarcoma in a 7-year-old girl: report of a case with molecular confirmation.
    Peng R; Chen H; Yang X; Zhang X; Zhang Z; He X; Zhang H
    Hum Pathol; 2018 Jan; 71():41-46. PubMed ID: 28705709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations.
    Codenotti S; Mansoury W; Pinardi L; Monti E; Marampon F; Fanzani A
    Onco Targets Ther; 2019; 12():5257-5268. PubMed ID: 31308696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
    Kilpatrick SE
    Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
    Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
    Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.
    Avallone G; Roccabianca P; Crippa L; Lepri E; Brunetti B; Bernardini C; Forni M; Olandese A; Sarli G
    Vet Pathol; 2016 Jul; 53(4):773-80. PubMed ID: 26993784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives.
    Nishio J; Nakayama S; Nabeshima K; Yamamoto T
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-Differentiated Liposarcoma With Hibernoma-Like Morphology.
    Hallin M; Schneider N; Thway K
    Int J Surg Pathol; 2016 Oct; 24(7):620-2. PubMed ID: 27272683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
    Ng W; Messiou C; Smith M; Thway K
    Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.
    Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL
    Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Aggressive Behavior of
    Ben Salha I; Zaidi S; Noujaim J; Miah AB; Fisher C; Jones RL; Thway K
    Rare Tumors; 2016 Sep; 8(3):6282. PubMed ID: 27746879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient.
    Kukull BJ; Khalighi MA; Gundle KR; Hansford BG; Corless CL; Davis JL
    Pediatr Dev Pathol; 2020; 23(3):240-246. PubMed ID: 31739757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipomatous tumors.
    Weiss SW
    Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 Immunohistochemistry is Less Useful Than MDM2 and CDK4 to Distinguish Dedifferentiated Liposarcomas From Other Retroperitoneal Mimics.
    Kang Y; Horvai AE
    Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):58-63. PubMed ID: 26509911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.
    Thway K; Wang J; Swansbury J; Min T; Fisher C
    Sarcoma; 2015; 2015():812089. PubMed ID: 25810689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.